NewGenIvf Group Limited
NIVF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $46,110 | $553,131 | $517,609 | $498,833 |
| - Cash | $458 | $54 | $55 | $29 |
| + Debt | $3,030 | $333 | $452 | $926 |
| Enterprise Value | $48,682 | $553,410 | $518,007 | $499,730 |
| Revenue | $5,433 | $5,136 | $5,944 | $4,118 |
| % Growth | 5.8% | -13.6% | 44.3% | – |
| Gross Profit | $1,827 | $1,682 | $1,538 | $1,025 |
| % Margin | 33.6% | 32.7% | 25.9% | 24.9% |
| EBITDA | $24 | $384 | $726 | $587 |
| % Margin | 0.4% | 7.5% | 12.2% | 14.3% |
| Net Income | -$525 | $130 | $459 | -$1 |
| % Margin | -9.7% | 2.5% | 7.7% | -0% |
| EPS Diluted | -115.25 | 64.25 | 323 | -0.025 |
| % Growth | -279.4% | -80.1% | 1,292,100% | – |
| Operating Cash Flow | -$8,264 | -$1,766 | -$527 | $1,433 |
| Capital Expenditures | -$53 | -$70 | -$94 | -$17 |
| Free Cash Flow | -$8,317 | -$1,836 | -$622 | $1,416 |